868 results on '"Morris, J. C."'
Search Results
102. 299 BIOACTIVE, BACTERIAL-DERIVED RECOMBINANT BOVINE FOLLICLE-STIMULATING HORMONE
103. How Will Aducanumab Approval Impact AD Research?
104. Cognitive profiles in dementia: Alzheimer disease vs healthy brain aging
105. Phase I/II study of GC1008: A human anti-transforming growth factor-beta (TGFβ) monoclonal antibody (MAb) in patients with advanced malignant melanoma (MM) or renal cell carcinoma (RCC)
106. Breast involvement in patients with HTLV-1-associated adult T-cell leukemia/lymphoma (ATL)
107. A longitudinal study of drivers with Alzheimer disease
108. AMERICAN ACADEMY OF NEUROLOGY POSITION STATEMENT ON PHYSICIAN REPORTING OF MEDICAL CONDITIONS THAT MAY AFFECT DRIVING COMPETENCE: TO DRIVE OR NOT TO DRIVE: ROLES OF THE PHYSICIAN, PATIENT, AND STATE
109. α-Fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma
110. Leonard Berg, MD (1927 2007)
111. Pilot phase I study of gefitinib (GEF) in combination with paclitaxel (PAC) and radiation therapy (RT) in patients with locally advanced head and neck squamous cell carcinoma (HNSCC) and effects on epidermal growth factor receptor (EGFR) signaling pathway
112. Personality traits distinguishing dementia with Lewy bodies from Alzheimer disease
113. American Academy of Neurology position statement on physician reporting of medical conditions that may affect driving competence
114. Fluctuations of CSF amyloid-ss levels: Implications for a diagnostic and therapeutic biomarker
115. Education and Alzheimer disease without dementia: Support for the cognitive reserve hypothesis
116. Measurements of electrical and thermal conductivity of hydrogen, nitrogen, and argon at high temperatures
117. Validity and reliability of the AD8 informant interview in dementia
118. Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease
119. Clinical phenotype of Parkinson disease dementia
120. Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI
121. [11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease
122. Clinical, signaling pathway, and cellular effects of epidermal growth factor receptor (EGFR) inhibition with gefitinib in combination with paclitaxel and radiation in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
123. A phase II study of the efficacy and toxicity of alemtuzumab for the therapy of human T cell lymphotrophic virus-1 (HTLV-1)-associated adult T-cell leukemia/lymphoma (ATL)
124. A phase I study of antitumor vaccination using tumor cells genetically modified to express alpha(1,3)galactosyltransferase (αGT) in patients with refractory or recurrent non-small cell lung cancer (NSCLC)
125. Mid-Season Prediction of Wheat-Grain Yield Potential Using Plant, Soil, and Sensor Measurements
126. Verbal and visuospatial deficits in dementia with Lewy bodies
127. Driving and Dementia of the Alzheimer Type: Beliefs and Cessation Strategies Among Stakeholders
128. Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice
129. The AD8
130. Phase I trial of siplizumab in CD2-positive lymphoproliferative disease
131. Phase I study of an antitumor vaccination using α(1,3) galactosyltransferase expressing allogeneic tumor cells in patients (Pts) with refractory or recurrent non-small cell lung cancer (NSCLC)
132. The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs
133. Complement Activation in Very Early Alzheimer Disease
134. Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD
135. Alzheimer disease and cancer
136. Ascertain Dementia 8 Questionnaire
137. Ascertain Dementia Questionnaire-8
138. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer
139. Progressive posterior cortical dysfunction: A clinicopathologic series
140. The Sodium-Iodide Symporter
141. Lymphatic Drainage Imaging of Breast Cancer in Mice by Micro-Magnetic Resonance Lymphangiography Using a Nano-Size Paramagnetic Contrast Agent
142. Trans‐complementing adenoviral vectors for oncolytic therapy of malignant melanoma
143. Rofecoxib: No effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study
144. Understanding of informed consent by demented individuals
145. Finasteride reduced prostate cancer but led to more high grade tumours and sexual side effects
146. MRI measures of entorhinal cortex versus hippocampus in preclinical AD
147. Rates of progression in mild cognitive impairment and early Alzheimer's disease
148. The clock drawing test is a poor screen for very mild dementia
149. Glycolysis modulates trypanosome glycoprotein expression as revealed by an RNAi library
150. Contribution of APOE promoter polymorphisms to Alzheimer’s disease risk
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.